share_log

Dyne Therapeutics(DYN.US) Director Sells US$6.05 Million in Common Stock

Moomoo News ·  Aug 30 16:11

$Dyne Therapeutics (DYN.US)$ Director Kersten Dirk sold 134.26K shares of common stock on Aug 28, 29, 2024 at an average price of $45.03 for a total value of $6.05 million.

1725048705709690081.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment